You just read:

MEI Pharma Presents Clinical Results for ME-344 in Combination with Bevacizumab in Early HER2 Negative Breast Cancer Patients at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

News provided by

MEI Pharma, Inc.

Jun 01, 2019, 09:00 ET